Cystic fibrosis-related deaths in infancy and the effect of newborn screening

Pediatric Pulmonology

Volumn 31, Issue 5, 2001, Pages 363-366

  Doull, Iolo J M ^a   Ryley, Henry C ^b   Weller, Peter ^a   Goodchild, Mary C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Life expectancy; Newborn screening

Indexed keywords

TRYPSIN;

ARTICLE; CHILD DEATH; CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOREACTIVITY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MECONIUM ILEUS; NEWBORN; NEWBORN SCREENING; PATIENT CODING; PRIORITY JOURNAL; RANDOMIZATION; UNITED KINGDOM;

CYSTIC FIBROSIS; FALSE NEGATIVE REACTIONS; HUMANS; INFANT, NEWBORN; INTESTINAL OBSTRUCTION; MECONIUM; NEONATAL SCREENING; RISK FACTORS; TRYPSIN;

EID: 0035002540     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1059     Document Type: Article

References (15)

1. Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test
2. Nutritional status in infants with cystic fibrosis associated with early diagnosis and intervention
3. Long-term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre
4. Clinical outcomes of newborn screening for cystic fibrosis
5. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95
6. Clinical outcome in relation to care in centres specialising in cystic fibrosis: Cross sectional study
7. Nutritional benefits of neonatal screening for cystic fibrosis
8. Screening for cystic fibrosis: A comparative study
9. Neonatal screening for cystic fibrosis in Wales and the West Midlands: Clinical assessment after 5 years of screening
10. Neonatal screening for cystic fibrosis in Wales and the West Midlands: Evaluation of immunoreactive trypsin test
11. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas, utilising pilocarpine by iontophoresis
12. Neonatal screening for cystic fibrosis using immunoreactive trypsinigen and direct gene analysis: Four years experience
13. Sweat testing for the diagnosis of cystic fibrosis: Practical considerations
14. Sweat testing following newborn screening for cystic fibrosis